ArticleTherapeutic advances in neurological disorders2021
Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate.
Thomas F Scott et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.